Alexandre Ingels
Onze Lieve Vrouwziekenhuis Hospital, Université Paris-Est Créteil, Inserm, Institut Mondor de Recherche Biomédicale, Institute Mutualiste Montsouris, Centre Hospitalier Universitaire Henri-Mondor, Assistance Publique – Hôpitaux de Paris, European Association of Urology, Hôpitaux Universitaires Henri-Mondor
Papers
20
Total Citations
315
H-Index
10
About
Dr. Alexandre Ingels is a leading urologic oncologist whose research centers on robotic and minimally invasive surgery for kidney and prostate cancers, with a particular focus on optimizing partial nephrectomy techniques. His major contributions include landmark comparative studies demonstrating the safety and efficacy of robotic-assisted partial nephrectomy (RPN) versus open approaches, as evidenced by his multicentric UroCCR-47 study (46 citations) and the NEPRAH study comparing hilar and nonhilar renal masses (15 citations). Dr. Ingels has also advanced clinical guidelines, co-authoring the French AFU Cancer Committee recommendations for kidney cancer management (2022, 51 citations; 2024, 10 citations), which shape national practice. His systematic review of resection techniques during RPN (56 citations) provides essential guidance for surgeons, while his work on perioperative management—such as the safety of aspirin continuation during robot-assisted radical prostatectomy (18 citations)—addresses critical clinical questions. With over 200 citations across his most influential papers, Dr. Ingels’ research has directly improved surgical outcomes and patient care, establishing him as a key figure in the evolution of robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1Resection Techniques During Robotic Partial Nephrectomy: A Systematic Review56 citations · 2023
- 2
- 3
- 4
- 5
- 6Postoperative outcomes of elderly patients undergoing partial nephrectomy17 citations · 2021
- 7
- 8
- 9
- 10